Mintrax S 250mg/125mg Injection
Marketer
Mint Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Mintrax S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must always be overseen by a medical professional. Strict adherence to the prescribed dosage schedule is crucial; completing the full course is vital even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Prior to commencing treatment, disclose all current medications to your physician. Pregnant or lactating individuals must consult their doctor. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your physician may order laboratory and imaging studies to monitor therapeutic response.
Primary Ingredients of Mintrax S 250mg/125mg Injection
No text was provided to rewrite.
Uses of Mintrax S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Mintrax S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Mintrax S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Mintrax S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mintrax S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Mintrax S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Mintrax S 250mg/125mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Mintrax S, 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Mintrax S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Mintrax S 250mg/125mg can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mintrax S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Mintrax S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. For patients with mild to moderate liver dysfunction, dosage alteration of Mintrax S 250mg/125mg Injection is not advised. Physician consultation is recommended.
What if you forget to take Mintrax S 250mg/125mg Injection :
Should you omit a scheduled dose of Mintrax S 250mg/125mg Injection, seek medical advice.
Facts to Know About Mintrax S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently